A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers

Inclusion Criteria: * Subject provides written informed consent before any study-specific evaluation is performed. * Subject is a healthy adult male or female volunteer between the ages of 18 and 45 years, inclusive. * Subject has no clinically significant abnormalities on the basis of medical history, physical examination findings, or vital sign measurements, as judged by the Investigator. * Subject is able and willing to comply with the protocol and study procedures. Exclusion Criteria: * Subject is a woman who is pregnant or breastfeeding. * Subject has clinically relevant abnormalities in the screening or check-in assessments. * Subject has received an investigational drug within 30 days before the first dose of study drug.